Dr. Sheikh has over 30 years of international pharmaceutical industry experience with extensive drug development and leadership background in multinational companies including, Roussel Pharmaceuticals (now a part of Sanofi-Aventis) and AstraZeneca.  His industry experience covers a wide range of successful technical leadership and management roles in a variety of areas including strategic and operational planning, CMC development of parenteral & topical dosage forms and antimicrobial drug products.  He co-founded and established SL Pharma Labs in 1997, and has built the company into a well-run, successful and highly regarded  pharmaceutical CRO/CDO. At SL Pharma Labs, Dr. Sheikh, has built strong project management, technical leadership and quality teams that have helped the company to earn an enviable and impressive track record of achievements including successful completion and regulatory approval of numerous innovator and generic drug products. He acts as a technical leader and advisor in addition to performing his primary responsibilities as the president of the company. Dr. Sheikh earned his Ph.D. in Pharmaceutics and Microbiology from University of London. Dr. Sheikh has over 30 years of international pharmaceutical industry experience with extensive drug development and leadership background in multinational companies including, Roussel Pharmaceuticals (now a part of Sanofi-Aventis) and AstraZeneca.  His industry experience covers a wide range of successful technical leadership and management roles in a variety of areas including strategic and operational planning, CMC development of parenteral & topical dosage forms and antimicrobial drug products.  He co-founded and established SL Pharma Labs in 1997, and has built the company into a well-run, successful and highly regarded  pharmaceutical CRO/CDO. At SL Pharma Labs, Dr. Sheikh, has built strong project management, technical leadership and quality teams that have helped the company to earn an enviable and impressive track record of achievements including successful completion and regulatory approval of numerous innovator and generic drug products. He acts as a technical leader and advisor in addition to performing his primary responsibilities as the president of the company. Dr. Sheikh earned his Ph.D. in Pharmaceutics and Microbiology from University of London.

hepatology